1958 - roald.ro

12
1958 Course Directors Liana GHEORGHE Ioan SPOREA Anca TRIFAN Scientific secretary: Speranta Iacob

Transcript of 1958 - roald.ro

Page 1: 1958 - roald.ro

1www.roald.ro

1958

Course DirectorsLiana GHEORGHE Ioan SPOREA Anca TRIFAN

Scientific secretary: Speranta Iacob

Page 2: 1958 - roald.ro

www.roald.ro2

Hotel Pullman

10 Montreal square

District 1

011469 BUCHAREST

ROMANIA

Page 3: 1958 - roald.ro

3www.roald.ro

Dear colleagues and friends,

Once again, it is my great pleasure to welcome you to the Update on Hepatology 2021.

This year’s course will address the topic Updates and Debates in Liver Diseases and will be running in hybrid form.

With the perfect blend of online and on-site (face-to-face) participation, you will be engaged with expert faculty and colleagues through roundtable discussions, live Q&A and educational sessions, networking and maximizing learning outcomes in the field of chronic liver diseases.

The topics that have been selected give us the opportunity to develop the latest clinical advancements, as well as the remaining challenges and controversies.

Our goal remains to deliver up-to-date knowledge, to help our liver community stay connected and maintain the commitment to lifelong learning in hepatology during these challenging times.

We are grateful to the faculty members who have stepped up to provide such an insightful and clinically useful event, to all the participants who join us, and, last but not least, we are grateful to our industry partners for their generous backing.

On behalf of the organizing and scientific committee, thank you for attending, your continued interest and support, looking forward to an exceptional scientific and practice-changing event

Course Directors: Liana Simona Gheorghe, Anca Trifan, Ioan Sporea

Scientific secretary: Speranta Maria Iacob

Page 4: 1958 - roald.ro

www.roald.ro4

Title8th Update on Hepatology Course 2021

Time: 10th-12th June 2021

Venue: HYBRID

INTERNATIONAL FACULTY

Costica Aloman Chicago USA

Maria Reig Barcelona Spain

Scott Friedman New York USA

Vlad Ratziu Paris France

Pietro Invernizzi Milano Italy

Shiv Sarin New Delhi India

Vito Cicinnati Munster Germany

Pal-Dag Line Oslo Norway

Jasmohan Bajaj Richmond USA

Erwin Santo Tel Aviv Israel

Nancy Reau Chicago USA

Susanne Beckebaum Munster Germany

NATIONAL FACULTY

Anca Trifan Iasi

Mircea Diculescu Bucharest

Liana Gheorghe Bucharest

Dana Crisan Cluj-Napoca

Roxana Sirli Timisoara

Razvan Iacob Bucharest

Zeno Sparchez Cluj-Napoca

Mugur Grasu Bucharest

Adina Croitoru Bucharest

Ioan Sporea Timisoara

Speranta Iacob Bucharest

Irinel Popescu Bucharest

Bogdan Procopet Cluj-Napoca

Dana Tomescu Bucharest

Mihai Popescu Bucharest

Cristian Gheorghe Bucharest

Andrada Seicean Cluj-Napoca

Ioana Lupescu Bucharest

Camelia Cojocariu Iasi

Catalin Copaescu Bucharest

Carmen Ester Bucharest

Alina Popescu Timisoara

Ionut Saizu Bucharest

Mihaela Ghioca Bucharest

Larisa Sandulescu Craiova

Roxana Vadan Bucharest

Irina Girleanu Iasi

Daniel Coriu Bucharest

Corina Pop Bucharest

Sorina Diaconu Bucharest

Gabriela Stefanescu Iasi

Dan Ionut Gheonea Craiova

Eugen Dumitru Constanța

Gabriel Becheanu Bucharest

Page 5: 1958 - roald.ro

5www.roald.ro

Thursday, 10 June 2021Updates in Clinical Hepatology

12.10-13.40 Session 1 Role of gut microbiota in the pathogenesis and therapy of

chronic liver diseases Chair: Anca Trifan, Mircea Diculescu

12.10-12.30 The role of gut microbiota and its manipulation in advanced liver disease Liana Gheorghe, Bucharest

12.30-12.50 NAFLD/NASH-induced gut microbial alteration and therapeutic perspectives Dana Crisan, Cluj-Napoca12.50-13.10 Microbial dysbiosis and PSC/Cholestatic liver disease Roxana Sirli, Timisoara13.10-13.30 Immune sensing of altered intestinal microbiota in alcoholic tissue injury

Costica Aloman, Chicago13.30-13.40 Panel Discussion and Q & A Chat

13.40-13.50 Technical break

13.50-14.30 Educational Session organized by RoALD with support from NEOLA PHARMA

Chronic hepatitis C can be cured. How do we transform possibility to reality. Multiple questions. What answers do we have?

Speakers: Liana Gheorghe, Anca Trifan

14.30-16.20 Session 2 New/target therapy for advanced hepatocellular carcinoma Chair: Razvan Iacob, Zeno Sparchez

14.30-14.50 The role of transarterial radioembolization (TARE) for HCC Mugur Grasu, Bucharest14.50-15.10 Advances in systemic therapy for HCC Adina Croitoru, Bucharest15.10-15.30 Benefits and risks of immunotherapy Maria Reig, Barcelona

Page 6: 1958 - roald.ro

www.roald.ro6

15.30-15.50 Personalized therapy in HCC - new approach for liver cancer Razvan Iacob, Bucharest15.50-16.10 Multimodal approach of HCC: combining treatment modalities to improve outcome Zeno Sparchez, Cluj-Napoca16.10-16.20 Panel Discussion and Q & A Chat

16.20-16.40 Coffee break

16.40-18.00 Session 3 Recent advances in the development of antifibrotic drugs Chair: Ioan Sporea, Liana Gheorghe

16.40-17.00 New antifibrotic therapies in patients with chronic liver diseases Scott Friedman, New York17.00-17.20 Perspectives of antifibrotic therapy for NASH Vlad Ratziu, Paris17.20-17.40 Antifibrotic drugs for cholestatic liver diseases Pietro Invernizzi, Milano17.40-18.00 Panel Discussion and Q & A Chat Wrap up

Page 7: 1958 - roald.ro

7www.roald.ro

Friday, 11 June 2021Current Debates in Clinical Hepatology

12.00-13.30 Session 4 To transplant or not? Chair: Liana Gheorghe, Speranta Iacob

12.00-12.20 To transplant or not patients with ACLF grade III? Shiv Sarin, New Delhi12.20-12.40 DOACs in LT candidates: interpretation of coagulation assays and impact on

MELD Score Vito Cicinnati, Munster12.40-13.00 Liver transplant for extra-Milan hepatocellular carcinoma Irinel Popescu, Bucharest13.00-13.20 Liver transplant for metastatic colorectal cancer Pal-Dag Line, Oslo13.20-13.30 Panel Discussion and Q & A Chat

13.30-14.30 Educational Session organized by RoALD with support from ABBVIE

ABBVIE, trusted partner in HCV elimination! Elimination Leaders, Connect to eliminate HCV

Chair: Cristian Gheorghe Speakers: Liana Gheorghe, Dan Ionut Gheonea, Cora Pop,

Anca Trifan

14.30-14.50 Coffee Break

14.50-16.20 Session 5 Current controversies in liver cirrhosis Chair: Bogdan Procopet, Roxana Sirli

14.50-15.10 Albumin or Terlipressin for hepato-renal syndrome Horia Stefanescu, Cluj-Napoca15.10-15.30 Emergency TIPS or endoscopic therapy for uncontrolled variceal hemorrhage Bogdan Procopet, Cluj-Napoca

Page 8: 1958 - roald.ro

www.roald.ro8

15.30-15.50 Long-term management of HBV infected liver transplant recipients Speranta Iacob, Bucharest15.50-16.10 Artificial liver support systems for Acute on Chronic Liver Failure Dana Tomescu, Mihai Popescu, Bucharest16.10-16.20 Panel Discussion and Q & A Chat

16.20-16.50 Educational Session organized by RoALD with support from Alfasigma

Prevention of Hepatic Encephalopathy Recurrence Chair: Liana Gheorghe Speaker: Jasmohan Bajaj, Richmond, Virginia, USA

16.50-18.20 Session 6 Biliary strictures: dilate, stent or operate? Chair: Cristian Gheorghe, Andrada Seicean

16.50-17.10 Cross-sectional imaging for biliary strictures – radiologist’s perspective Ioana Lupescu, Bucharest17.10-17.30 Biliary strictures in primary sclerosing cholangitis Andrada Seicean, Cluj-Napoca 17.30-17.50 Biliary malignant strictures Cristian Gheorghe, Bucharest17.50-18.10 Biliary strictures after liver transplantation Erwin Santo, Tel Aviv18.10-18.20 Panel Discussion and Q & A Chat Wrap up

Page 9: 1958 - roald.ro

9www.roald.ro

Saturday, 12 June 2021Debates & Updates in Clinical Hepatology

09.00-10.30 Session 7: Current controversies in NAFLD/NASH Chair: Anca Trifan, Ioan Sporea

09.00-09.20 Lean NASH Anca Trifan, Camelia Cojocariu, Iasi09.20-09.40 Bariatric surgery in NASH Cirrhosis Catalin Copaescu, Bucharest09.40-10.00 Liver biopsy vs. Elastography to diagnose NASH Ioan Sporea, Timisoara10.00-10.20 Biomarkers vs. Clinical factors for NASH prognosis Nancy Reau, Chicago10.20-10.30 Panel Discussion and Q & A Chat

10.30 - 10.40 Technical break

10.40-11.00 State of the Art lecture European Board of Transplant Medicine - Harmonization of

specialists‘ qualification across Europe Susanne Beckebaum, Munster

11.00-11.30 Educational Session organized by RoALD with support from INNERGY

The use of pharmabiotics in the treatment of gastrointestinal and liver diseases.

Speakers: Liana Gheorghe, Eugen Dumitru

11.30- 13.10 Session 8: Case-based Debates in Hepatology

Channel 1 11.30-12.20 Idiosyncratic DILI: a challenging diagnosis in clinical practice Presenter: Carmen Ester, Bucharest Experts: Gabriel Becheanu, Bucharest, Liana Gheorghe, Bucharest, Alina

Popescu, Timisoara

12.20-13.10 Primary sclerosing cholangitis and inflammatory bowel disease - a complex interplay

Presenter: Ionut Saizu, Bucharest, Mihaela Ghioca, Bucharest Experts: Larisa Sandulescu, Craiova, Roxana Vadan, Bucharest

Page 10: 1958 - roald.ro

www.roald.ro10

Channel 2 11.30-12.20 A multidisciplinary approach to the diagnosis and management of Budd-Chiari

syndrome Presenter: Speranta Iacob, Bucharest Experts: Irina Girleanu, Iasi, Daniel Coriu, Bucharest

12.20-13.10 Decompensated cirrhosis following COVID-19 infection Presenter: Sorina Diaconu, Bucharest Experts: Corina Pop, Bucharest, Gabriela Stefanescu, Iasi

Page 11: 1958 - roald.ro

11www.roald.ro

Page 12: 1958 - roald.ro

Romanian Association for Liver Diseas (RoALD)

12 CME for three days course

DATE: 10th-12th June 2021Location: Hybrid